The word cancer is a fairly non-specific term and includes a variety of diseases stemming from abnormal cell growth. There are many types of cancer and a number of proposed mechanisms or causes for the development of aberrant cell growth including the association between infectious agents (bacteria, viruses, etc.) and specific cancers. Hemangiosarcoma is a very aggressive type of cancer with a poor short-term and long-term prognosis.

Edward Breitschwerdt, DVM, DACVIM is a veterinary internal medicine specialist and researcher at North Carolina State University - focused on studying vector borne diseases, with a particular interest in Bartonella spp. He spoke with us about what he and his research group have learned about the role of Bartonella spp. in the development of hemangiosarcoma in dogs.

Bartonella spp. are stealth bacterial pathogens. A One Health approach to this emerging infection is defining disease manifestations, establishing the comparative disease pathogenesis for these bacterial pathogens, providing insights into effective treatment regimens, and elucidating strategies to prevent zoonotic disease transmission from animals to humans. Dogs and humans develop nearly identical types of pathology when infected with a Bartonella spp. As such, defining the role of these bacteria in dogs with hemangiosarcoma may provide important comparative oncology lessons for veterinary and human medicine. In this presentation Dr. Breitschwerdt discusses Bartonella spp. and what we know about the relationship between infection with this bacteria and hemangiosarcoma in dogs. His discussion includes:

• Bartonella lesions that occur in dogs and humans
• The mechanisms by which bacteria might cause cancer
• The potential sources of Bartonella spp. exposures and modes of organism transmission to dogs
• The mechanisms by which Bartonella spp. may contribute to the development of hemangiosarcoma
• The benefits and limitations of serological, molecular and enrichment culture tests for the diagnosis of bartonellosis in dogs with hemangiosarcoma
  
  Running time: 37 mins
  Approved for 0.5 hrs of CE credit by AAVSB RACE and NY State

You might also like

Hemangiosarcoma - What We Know And How That's Changing The Paradigm Of Treatment And Prevention

11/13/2024

Hemangiosarcoma is a malignant tumor and, historically, associated with a poor long term prognosis....

Read More

Treating Cancer - It's Not Just Limited To "chemo" Or "radiation"

11/06/2024

There are different approaches to cancer treatment and, for some types of cancer, the therapy may be...

Read More

The Current Thinking About What Cancer Is And Its Possible Causes

10/23/2024

Cancer is a term that is often shrouded in uncertainty and fear, but gaining a clear understanding o...

Read More

Protein-Losing Enteropathy - Therapeutic Management And The Crucial Role Of Nutrition

09/17/2024

In this second session (of a two part series) Dr. Jablonski continues the discussion on patient mana...

Read More

Protein-Losing Enteropathy In Dogs - Making The Diagnosis

09/10/2024

In this first session (of a two part series) Dr. Jablonski creates a comprehensive understanding of...

Read More

Mastering IMHA In Dogs - Part I: Approaches To Diagnosis And Standard Management

07/23/2024

This is the first of a two part series on the topic of immune-mediated hemolytic anemia (IMHA) in do...

Read More